Evertt Laboratories Acquires Quinnova Pharmaceuticals

December 19, 2013

Everett Laboratories acquires Quinnova Pharmaceuticals, a specialty pharmaceutical company.

Everett Laboratories, a privately held specialty pharmaceutical company and a subsidiary of Exeltis, headquarted in Madrid, Spain, has acquired Quinnova Pharmaceuticals, from parent company Amneal Enterprises.

The acquisition will result in the strategic expansion of Everett into the US dermatology market.

Summary: Everett Laboratories